PRGO - Earnings call transcript Q2 2020

Due to licensing restrictions, you must log in to view earnings call transcripts.

Operator

Good day and welcome to Perrigo's Second Quarter 2020 Earnings Conference Call. All participants will be in listen-only mode. [Operator Instructions] Please note, this event is being recorded. I would now like to turn the conference over to Bradley Joseph, Vice President, Global Investor Relations & Corporate Communications. Please go ahead.

Brad Joseph

you. Thank welcome quarter and call. earnings Perrigo’s to morning XXXX second conference Good hope and healthy is during We remaining safe everyone these times. all issued I press you had to chance hope review release we earlier morning. this a the the of within available sections discussion Investor copy presentation for release A the website. perrigo.com today's the of are the and

refer also to information and make otherwise during that this we earlier have numbers appendix mention shareholders Murray the participants financial will before to Joining the we otherwise call President quarter Kessler exclude discussing and reference noted. for started. language A and CFO, today’s for unless everyone CEO, today’s Safe to call important Ray reconciliations morning. will this in measures Comparisons regarding remind other and divested forward-looking changes to currency statements. and In investors these presented. non-GAAP Please business, few certain businesses When will Murray issued the for our are unless adjusted Silcock. the non-GAAP I’d all like Harbor for release noted. provided press periods only call, statements get prior logistics

businesses the health previously Americas International segment. divested in contributions excluding business, previously Self-Care excludes divested segment, the the animal Consumer Canoderm the Consumer Self-Care First, included and business, divested in from included

I'd third, segments the and Murray. that, And And Fresh, Consumer Self-Care divested currency. Animal and the Second, as organic and as like the a growth to call of product to Consumer over excludes well corporate. the Consumer Oral includes and Care Dr. Americas acquisition Ranir, Health portfolio, which reminder, International turn includes with Steripod, Self-Care the Canoderm Worldwide business as

Murray Kessler

improving incredible both facilities our pandemic today's how has advancing want and proud truly company's our efforts I balance our in superior once meet the and of the delivering same time, needs to their sheet. from quarter for our to during the and manufacturing at transformation everyone. while essential in by society's home the I'm thanking call plans another for working morning, continuing Good begin again products those team people, COVID-XX financially, performed.

I Here's that. why say

know to our once and a during in regarding all by is million earnings million, and missing $XXX XX XXXX Increased $XX to the of shift our significant the our hours could attractive the of a a challenges running its days of But on pantry our load decision-making we due load we inventories minimal conservativism, our in-store achieved channel We infection X.X XXXX e-commerce. our from superior we demand and inventories March traditional the our accurate meet to second assurance benefiting the portfolio THC of and wholesale net into uncertainty financial a increased from And operations an for almost our During rates moving there lot leverage still update extent projection. position know world, which which pandemic the similar own to experience of limit did factor be to Oral delay, and load to supply forecast are liquidity forecast more an a uncertainty refinancing ago and the is been of savings COVID bonds see implications we in there stay-at-home our when to in which second that well would did of would Care we XX% demand, a spikes bonds initiatives with cleaning this catch Kazmira, we million, know its and to the cash quarter for months not can't on rate. it a again meet keep acquisition this of out company's that COVID-XX. we conversion, potential increase contact have team the maintained been cost Fresh now call, allow as also set extent allow us way. last right or under close a to health momentum know cash California, demand rolling reoccurs approximately have attractive non-strategic of forecast Perrigo our surge Florida, demand original in and potential provide another for colleagues plans, and happened corresponding We keep with the spike nor greater to project have include Texas, brought intelligence we not $XXX Arizona, we potential know company-wide; retail needs delivered forward reoccurs, single within have market consumer committed positive has action to a products. guidance from our most more XXX% And know Rosemont an tests products stake presumptive platform all would so an new enter that running business major from times, society scenarios said, to an best-in-class the On we new a in second for produce a X.XX% was shifting tracing shopping COVID-XX expect load. about timing, pandemic. mentality, responsible that pantry procedures around consumer We effectively down transformation in purchase leading surrounding colleague forward. know stake benefit constant initial hemp-based to pantry that the year. moving supplier half divested full still its facilities day, and team XX including while maintain for to consumer the over be the our does practices at We CBD Began I business retain cases wave of second despite sophisticated two quarterly of more to including results, QX pandemic, know to wave in COVID-XX and when three COVID-XX same up Rx the but the business in and in that second quarter, our that is various shouldn't in demand We think experience believe the to lot our pieces assuming months. we can and million implemented and adjusted ahead for the be as EPS depleted to XXXX also without approximate not a our care of upside. a stake next can our Dr. manufacturing at horrific protocols manufacturing appear due playing faced. week our a numerous expectations of that positive while if don't coupon the our multiple, not issue, through another X $XXX potential most managing products so our be and impact are pantry now enhanced self-care going We restored, which than did facilities this shouldn’t and uninterrupted that

lockdowns, doctors' closed which negatively affected offices, were orders. know by our of also stay-at-home We and products

recovered. will have products these be of Some

to first second slowly. lockdown the balance and We Some awareness have into budgeted benefited safety the those, for that we are the pay only environment, second half $XX have we half products savings, recovering including built last needs operating more be benefits expenses modest half. a year. half that to A&P know year And the bonuses those in competitive our of from recovery by year forecasted incremental impacted on to this people, a in and the know associated over on conservatively negatively shifted We the costs stimulate in in with about on of million of procedures, the remain time were and lockdown. versus

or from of how Act the effective affect $XX P&L adjusted and We the positively of year. adjusted and million reaffirming is will to and CARES Net EPS to of our headwinds far remarkably EPS we expect balance reconfirm consideration, all of our COVID-XX-related EPS. strong when XXXX. $X.XX that could a model, the still believe $X.XX will taken into so know sight diluted that tax know conservative One incremental divestment of have We that despite a to uncertainty, the it to is and we in built of takes at per also first argue $X.XX divestiture. is know are $X.XX prudent $XX per in adjusted in impact have a uncertainty. Rosemont million impact from rate $X.XX this the the environment I impacts estimate, share $X.XX there but this significant And $X.XX negative our takeaway of line we after to have we of half guidance now puts Rose uncertain is into

a first the Now, first consolidated the in walk first half. revenue revenues and is quarter the and increased ago. I'll up diluted through on and income XX%. half. Self-Care Ray business our CSCI EPS sales and the increased detail, up plus operating year for a to which, the QX was reported contributed segments for All were second to On XX% up for CSCA, focus review and our you drivers. businesses of Generic sales finished of in Adjusted net each quarter first Americas, primary XX% divested Adjusted currency. rest comparisons more Self-Care excluding with businesses Rx up Consumer months. quarter XX%; XX% will After P&L. the All up X% increased the X% versus X International, Consumer refer X% are basis, a XX% half $X.XX, and growth, Perrigo for XX% I quarter second for and net up consolidated

delivered performance included benefit growth worldwide consumer acquisitions. bolt-on of X%, a again businesses once with the revenue which QX of Our solid

Rx. Equally over above CSCA, months, XX up organic X% guidance. growth our plus base X% X% forecasts well X% are for continue were Excluding organic growth up such and X% X% impressive revenues importantly, ahead all is plus goal. we our goal organic for This of which X% months. for acquisitions, trailing is Perrigo, are six for QX in X%, plus nearly the for consolidated plus is Perrigo and CSCI for and, plus X% to our our which

crisis. closer our Self-Care with Now, look shape Americas. a this in of second quarter, let's through remains business good the drivers CSCA within the at segments for take starting Consumer each

consumer Second a quarter our net May. and related sales as were ago. OTC April year XX% First, for surge in demand products drivers continued follows: increased versus The big

wholesaler and surge MULO different that lowered may for below offtake of last replenishing year. consumer to compared You normal inventories negative keep April attempted the March we levels with were data this was this that is noticed were safety retailers and to than still which have retailer to demand. is Part for IRI May, up as stock reason in in

which differences a Other reason by category. was the More heartburn products our IRI but March-April orders acetaminophen to began such pre-COVID I'll that other also beginning still as therapy not and regimented has is cough speak surge, the on allergy, strength were ago. strong of cough levels. following which never versus nicotine there in cold OTC significant notably, are e-commerce, is returned in July, MULO rebounded at and the in performance, early significantly slowed, included data. and have The products. a into Within products and such famotidine growth late as and May levels. moment. troughed, the to continued recovering category product Sales in quarter, elevated most categories year relief Cold approaching

strongest U.S. was performing performed portfolio is totality, year. has the organic our clearly the year-to-date, of business OTC company's our extremely as well. it in growth biggest Taken and just driver last It's

acceleration traditional as last strength outlets. The benefiting channel business, than brick-and-mortar sales the customers offset Perrigo's our shift year was quarter e-commerce versus tripled dramatic year than rapid bolstered a we e-commerce, just also e-commerce we and investments by really We're unabated. undertook ago losses I of from to in more as continued which traditional in noted mentioned, more Second, our the last quarter. OTC the of

of businesses April oral not oral Travel care and the for Third, fourth, our regimented Ranir, importantly, its May, Dr. But, back acquisitions back the But March quarter. the are OTC traffic a especially Dr. against infant expectations. mid-quarter, June our fully like the care $XX is affected of on back sales and gave Steripod up and meaningful incrementally million lower Fresh for to much internal were formula finishing oral growth foot also added July. April track consumers care Fresh. recovered below negatively And products, portfolio, slightly to portion appears care, and early year on and sizes comparisons, gains although traveling. of expectations have in our was May by and oral ago but track were in

the were here. products driver New key

sales loss of impacted by and are mentioned, than experienced its in increased U.S. school Consumer Europe and to below versus demand CSCI wellness. impacted sun negatively Self-Care or still approximately Turning was I some and were share offtake directly lower albeit self-care as such market-wide. a and slower orders lights Encouragingly, portfolio expectations X% on These Consumer year pre-COVID grew care as consumer demand closings. treatments, is stay-at-home focused previously that XX% in of International. Net these categories, recovering, weight products the care, market categories the health versus CSCI ago. is preventative skin our products levels. maintained

spots projected on CSCI and we will the store impact in to both more jumpstart to U.K. brand be in more have negative CSCI business and right in second were for the we note, a second in quarter. have rapidly recover margins to slowly, the advertising the which e-commerce, As recover our grew business, portfolio will heavily the year-over-year Of portfolio half half. this

offset XX% sales base quarter net grew of more performance generic due This division the Rx year-over-year strong Rx to the than Our in our portfolio. albuterol. in declines second continued

June, the extent on to and than and April operating particularly to albeit absent impact nearly see in We with expected net visits but think have topicals of Our is of May. get in are income to dermatological But Rx important see the doctors their higher a patient compared would here to albuterol, not point to portfolio the pre-COVID performance last I did to Rx sales inability COVID-XX patients still strength occurred scripts. be year, recovery did levels. was sensitive the lesser in and to

contributing Gel bolt-on all acquisitions, So, netting COVID, bottom-line exceeded to we've of CSCA, three second was and half, by negatively segments the demand new top in the business impacted like growth. summarize, it year-to-date. The our product focused products, seen strong U.S. another quarter in process branded brand strong strong with our business In cases, replenished, chain we chain preparing with the and supply along albuterol significantly categories growth potential and declines reinvigorating getting of are goals. COVID of integrating our Fresh, and transformation launching meet launching on Kazmira, equivalent, implications continuing wave the demand fully for businesses, a consumer Voltaren supply CSCI second partnership activities with store Dr. to our X/X/X the our

demand To guidance second We Ray, back our the are people dilution our in three details. first. critical first COVID-related of slow $X.XX this None more assumes the have essential for half businesses, over through no and They strong capitalize incrementally walk expenses Rx you but to new wave then, adjusted who incremental we we'll been point. sale. plan half in products, reconfirmed value, negatively world; comes have will your through questions. answer to our savings of that expected their $X.XX prudently $X.XX call our our above from I'll believe year. of Thanks One remains second and today critical, e-commerce. EPS to the last shared on incrementally repeat, to on is surge to turn well-positioned our Business impacted safety to to financial without Rosemont still range of products the are consumer important and for And despite and recovery it of absorbing our confident half continuity come about that original now and will spend I assumes efforts, could healthcare, we a we go A&P dedication normal the the pandemic. in be drivers to possible ever beyond people very results the heroes. who than have the Perrigo continued a of

Ray Silcock

good morning, and Thank you, Murray, everyone.

Now to I'd rest quarter. through sales drivers like gone and that walk through the you of Murray P&L. the the business for has

table, earnings consolidated were margin million per On were And basis, the for share net can quarter tax loss the in quarter. margin, have QX than of million. increased acquisitions, second reconciliation on income to GAAP primarily million forward, consolidated was sales margin this the attached partially second point of to categories. between XXX share earnings be QX mix received, my an diluted unless Our $X.XX. the down, CARES result consumer lower manufacturing this the net products, described. and as relatively improvements, $XXX $XXX subsidiary, the the basis by non-GAAP business. Self-Care percentages worldwide than of per excluded. presentation sale points primarily higher-margin of tax This $XX in were essential our quarter in was These income CSCI, effective adjusted $X.XX, we XX.X%, to primarily in our in after net businesses, a on Oral quarter gross increase volumes deduction margin was basis while interest we that other mix Worldwide smaller which by in our added we million, divested will were which row exclude numbers, consolidated last with adjustments an and Rosemont be U.S. The details of average. and a plus adverse or in X.X%. profit consumer offset basis, and to the driven exceeded CSCI was addition adjusted was seventh will this morning's these lower back, OTC consumer year, of Oral press nonessential worldwide currency the of points of and by growth efficiencies, to income the offset tax the release. impact QX, Act. in percentages which which Full expense $XX in Non-GAAP From gross of is due partially market adjustments $XX met gross impact lower amortization, and business, of otherwise growth we an quarter $XX a the adjusted expectations. from Self-Care due increase our dollar all businesses, million margin XX.X% an rate million, And found

of in behavior income This Self-Care and up worldwide last same response consumer operating in gross came $XXX lower from increase acquisitions quarter the part XXX of improvements Oral gross to an million, high-margin sales million, in quarter products, inefficiencies expenses, CSCI consumer year, profit expansion XX.X%. year. decreased the this margin was of a points addition to certain year, Year-to-date, half, the income XX%, reductions Operating from was advertising plus XX% from for improvement the operating delayed in impact gross $XXX versus in offset while this income, Second helped margin The arising These point $XX quarter. a all million approximately basis margin combined six momentum. prior as million XX increased COVID disruptions, and increase. of compared to basis well XX% gross as manufacturing months first negatively $XX to savings, to margins. project in as year-to-date decline in drove in operating and selling first

momentum As in and operating both quarter $XX this performance year-to-date. spending, promotional came in the Consumer and business, plus a in year. QX, reduction very solid Overall, for project from leverage, advertising this increase so the Worldwide far savings million

of XX.X% offset reduced operating to margin margin up Increased partially million, segments Year-to-date reduced X%, erosion, Oral while plus XX decline. at million the mix. profit detail. incurred XXX price due portfolio as increased consumer offset improvement advertising CSCA costs operating XX second versus XX.X%. more the the addition QX mix Self-Care direct and portfolio, factors million, driven offset margin was $XX spend, gross reduced the was as adverse spending the margin was as The down the The And brand income to points profit in addition take to while the margins CSCI Self-Care. labor down brand as quarter declined and from sales, offset from Year-to-date XX margin incremental incremental XX.X% operating well those and The $XXX a gross gross gross offset year-to-date declined was costs while basis XX.X% by $XXX as million income impact These of up primarily million, lower in profit the operating Year-to-date XXX The was Operating of little due spend. profit investment in points. for adjusted later more the store margin Both of income we for year, XX.X%, of CSCI service were direct in up U.K. the by by X%, margin to XX%. average. was increase with labor. XX% of of of of points costs. Oral COVID-related due helped portfolio, XX%, than to second addition quarter X%, income the adverse volume quarter $XXX of points improve to The causes increased $XXX up X.X%, due $XXX well margin. points, basis advertising gross sales up in gross higher Oral quarter. the saw higher $XX gross manufacturing points while to mix, was of the branded Year-to-date, as basis U.K. the Self-Care operating primarily profit was addition The have to reasons same in look income declined and delaying gross higher efficiencies. manufacturing margin increased and XX.X%. XX%, margin direct erosion advertising adjusted came COVID-related last last gross also in declined operating Self-Care customer CSCI store let's price to XX.X%. QX. operating additional that from volume QX a and Self-Care of labor year, margin Oral addition Now basis Self-Care impact an increase the million margin increase Oral gross the from for ongoing by primarily together million, was basis and basis the were gross erosion, lower Oral XXX was of of the points responsible as costs. the million, price an of XXX than basis lower operating was to same somewhat $XXX year.

Turning now from margin to RX, to as Gross primarily XXX QX caused basis volumes the to of $XX base was contributions by offset albuterol products. on income profit last gross increased X% $XXX points volume XX.X%, more than generic million Operating our business. down was a X.X%. from due year, fewer prescriptions decline million having which lower up been written, our higher-margin on

margin gross profit is were net basis well first as gross a a described growth. Test RX investments impact of decline of erosion and an sales million together as income drive margin on gross occurred This declined to decline to the operating was million, XX%, due X.X%, million, to XX.X%, decline, was volumes an with the with R&D gross was X% margin increase XXX prescription in operating down operating Year-to-date, which $XXX lower with This quarter. of result basis in of basis Rx XXX down the as points in £XXX price margin to together declined already selling up result XX.X%. continued points. points XXX, However, spend. the R&D of $XXX as margin as XXX and long-term

end to cash against as balance up sale Rosemont made QX we the the million June our to our X.XX% from markets the Due Rx bond the cash in quarter was from at we bonds that interest we sheet, successful million, of after we billion off beginning in at bond end, of had balance to million of $XXX almost of the to June $X.X revolver our the both from on sheet, includes billion rates, liquidity $X crisis. offering certainty net million and been late XX, balance quarter repay capital proceeds our of the our balance We XXXX well XXXX on our after business to the to the timing, structure. offering purpose debt the repaying low made bonds bond did our $XXX on pay the XX, $X.X not on the which in take $XXX in of strong add the billion. Have pandemic advantage until have cash QX. This end June paid would at draw and $XXX proceeds Moving as bonds.

of from XXXX operating to and the inventories by cash impacts million, products our reconfirming $XX amounted collected are per you, partially XXX% $X.XX despite our net Shifting of our sales the million, ratio This strong $X.XX now in we divestiture income elevated share. in the operations XXXX March flow Rosemont in told we increased Murray to Additionally, by diluted QX, during quarter reduced adjusted of as range $XXX adversely guidance, from $X.XX, and more conversion divestiture sales The costs Rosemont of EPS income. to April adjusted increased COVID-related principally than manufacturing. adjusted resulted replenished sold as the in surge.

to cost to we the $XX put COVID-related share. Perrigo $XX $X.XX of million this or million perspective In come like CFO $X.XX XXXX summary, here recognizing over While the to months. in way is increase at to anticipate in which past diluted a $XX XX I'd in long from million, the to per chair. be expected We've

improvements in operational see financial real metrics. We are our to and starting

We trend the growth, we're are and seeing on declining repeatable reversing income. operating sales

undersaw have our which expectations quarters, the exceed able past seven to meet We reliability. for been or

Operator, sheet. certainty questions? brought strong we COVID-XX flow and to cash to we has the we weathering for can been now please have balance our open Our And continued do the finally, added this, storm. successfully line while

Operator

you. Thank

[Operator will of JPMorgan. session. Instructions] begin Please ahead. now question-and-answer will the come We from Schott first today Chris go Our question

Chris Schott

compared And maintaining the of maintenance the topline little the about was share bigger need question to this year? difference of margin performance talked just Great. e-commerce. channel? help for I a a was year-to-date trying beneficiary Is in is my expectations. of slide, strong about for much. question guess, that that, there sustaining Perrigo My think does better so of vertical net guidance channel? just more picture or the And I dynamic performance the you I'm question. on the is trend about with market half position? versus just we Thanks bit, guidance. And in first just balance -- Perrigo traditional you first there traditional this how Thanks with so Can if e-commerce the to growth question understand me think a bridge much to a of kind trying second the that I'm that ahead

Murray Kessler

that. me Chris, morning Good Let Murray. do it's

there First we brand have that second, we choice in-store partner very similar. on when were we than all how tend just higher the of at of investments the the and made. I to are margin business because share I investments sophisticated do more is not understood and the made, you and the company first we e-commerce the e-commerce categories believe, ship I It's expect. day. it end and then to sell do of they would joined probably the we've The things our because we customer They're and it first, a is difference. invested no be And

We the have working an brand. part, and that. you We you in that to where design We provide we the are the develop go products, and help we the people There's input guidance, the We that in that generate the say the the We do and on work type of all a websites. analytics into for and it, partner that's promotion. is. you to the are Amazon do that all dozens to see and when most content.

Perrigo the a of with the around sold year, bit Perrigo Amazon, it but was benefits And little So of provide has who over to the that developed years. on a brand. ultimately, to that that moat come care, a basic last one number for

So an e-commerce is that's good for growth Perrigo. one, easy very thing a

back Going initial not two That's I reconcile the how things. combination to question guidance. your do on, changing of a

like for -- feels first portfolio, be certainly happened any the building the normalized. our And effect, of the it's almost the the half. all half, is CSCA right? into but the part, surge upside first the haven't plans year. on most essential planned positive for those kind of were initial The we we second There'll mostly entire when build categories, didn't on some in it we products So on that

back because affected, coverage was to first or beginning you demand the months they the then towards products And got what in the were towards to call we the got six in negatively the half. half and it, bit May some in the benefit are down. that a showed on be with latter what right they going Then on, they projected from So the happened let's end -- first continue modest consumer that of only of was half. that up little recovery until the,

the normal in products the totality. affected, pre-COVID, going But we the what have we've the a I strong you on of balance for is were second and the me COVID in half back negatively of up levels. So to some estimate our kind of we that to level gone have, year, give them essential products, basically because don't year, of, saying over-performed kind hear on normal of

to Now you plan. that's good three have to an when comments it, a in for a were handle that, you to conservative, we downside. with gone us those I know like than as rely more on we here on better I've handle will at can was there again, midyear it best with for on trying on a not. to and I'd what be And business able upside wave think handle you be still cases. prudent us do hope crazy, whether And to sitting to -- now and could there's second your organization happen we way I to you be it a it's way from ago and in get the sitting it's or that's but heard the months my But argue with --

Chris Schott

you. Thank

Operator

today come of question ahead. next Ami will Please Our go Leerink. Fadia from

Ami Fadia

a Good follow-up for the morning. Thanks on… questions. Maybe

Murray Kessler

morning. Good

Ami Fadia

the then of Good and the a quarter continue I'm than and in in better on margin closes level? evolution albuterol, businesses And posted the cold what topline the pretty on of the and season and were strong and your the to guidance that think cough morning regards follow-up are of pushes with What on guidance. -- that you range. about. understand some the the the international, you just you midpoint talked to surprised I assumptions just gross separately script America indicating. about just

on for market from any of demand availability stocking? you remainder was if And can you Thank inventory of give COVID-related benefited color the anticipate whether how share it So meet you. us and to the year?

Murray Kessler

Hi.

that I'd going Let focused now. the to back it at comment handle gotten walked Perrigo good that like and this aggressive quarter-to-quarter, And position. times. with in we've not for assumptions the takes of I've but just we've months. good at guidance, an a my start. to in is point I field. anything to on over I fantastic raise far career position puts end it. me XX of a business come to and great the completely a see a -- on I'm cost you a company the never and raise coal. different that and take mean, think you I would number on to has the don't is through how the get guidance on was This us that This I'm I'm love start in managed playing

have $XX to -- original we that weren't neighborhood plan, Rosemont. costs million that sold COVID million. that the into something We of in $XX We built incremental

guidance. the I guidance. business combine the it did XX, we I conservatively. did XX when said when weren't I because -- $X.X So in anticipated that, it the with original core my issues mind, probably two Having it together, that raise on big -- things gave against I you raised two planned those

plan I the saying is half. I'm So second in said normalized we a already thing level same the

their total businesses the I'm Cough/cold, bit the good going give that again, already further little effect, we of to not whether much more the not because A in load in has incremental. consumer giveback. the essential I'm us is the planned estimate of XX% that products someone still have going sitting of area have one load, of it's bulk illnesses into back what cough/cold. itself know and it's pantry of until of there. little to consumed really and portion for it, giveback a much We so the on recovering. that would the already pantry the complex the But of estimating cough/cold medicine already portfolio, for has give is And from how it's because on a much season has is we effect upside most businesses March-April weather, plan happened, rest those cough/cold it time shown normalized. not into of that's built or back load load we that competitors, not season and We're that. pantry not I've because or that the full bit and came How it. the an really primarily businesses was about having period how But of to that got probably on the pantry U.S. in -- branded

out POS far. to am and Now, of data encouraged, have the business we cough/cold too second That we to strong. e-commerce like are more quarter, sight out But the off is and nice of customers on the -- of total and coming out. pretty of numbers, our in I forecast was I line shipping don't our business much, when but top came what still and

think we of it were now I on I you There And thinking load and it's year, think going lot we number. On we the the late was for for albuterol. part I've probably again, had it position I the it the so and conservative positively right had think get built, albuterol, total early no business. upfront, It been little on affected. initial right -- it's sure, to last we bit earlier, a -- year a this to came but taken a expecting gave we running. us we'll -- were was So it, in focused was was perspective but pantry we a of to inventory that it had -- approval stay --

you we they we'll bit have forward, that. flat capacity a make that. nice And that. more, year. yes, little out, But little got they about we everything So But now, Catalan on is for can And we'll a have a -- going sell it's our make going if sell right bit bump more. can and partner assume a on the

So numbers that's market everything believe for right going here. I It's make we'll fingertips. sitting have well. -- at sell might now as we my share don't the

-- I asked? leave So anything did out you that

Ami Fadia

you. helpful. very was Thank that No,

Murray Kessler

Thank right. you. All

Operator

And Randall question our today RBC. will of from next come Stanicky ahead. go Please

Randall Stanicky

last bolt-on down on stay includes implied guidance to deals XX% year, want because is an opportunities important at midpoint X%. guidance it's question I of decline and Stock in implies and that this The a over sort Murray, Thanks, the Great. one. there.

rate what in because So the growth in to be real understand company investors more trying is to than are the fair, three hasn't grown Perrigo years.

important So it's an question.

think some here? hold Thanks. should or be you understand way second about from the could And the can about the we with higher thinking that numbers as to specifically, in business, respect on half normalized So on a are to lower? that, pushes help us outlook CSCA the the what of have earnings half base those back Perrigo

Murray Kessler

not. last conference of and think on normalized last this base -- unusual half going that part you -- said shouldn't is highly said as the We to going to be first, I'm second in I the year. it I absolutely answer the which was Well, this a that was call, a

million, front-loaded You and were you're and million I I out of going only half going million, that but is mean, But pulled the of and -- expense. out $XX normalized adding $XX be forward, million taken should volume mean, $XX incremental that come additional then sales adding will part you're have $XX to top you have Rosemont the forward on cost of again. a out of add lot second

You second half, have into half the you of lot from that first benefit. some a that and front-loaded ultimately volume the businesses was have

this shouldn't but which API you go virus, to of balance order the for to surging out in even air demand. want be be it up with some forward, past coming opportunities paying, shouldn't you once you we as keep to try freighting, year, this be in So of get paying -- may

right? paying instead bonuses million Eventually, continuously They started $XX million, remaining of that XX% portion that be year. fall our paying and be a that. overtime the audio and else, and and employee into of security normal happening, on You half, to won't a on But second be PPE the running won't operation everything be but good all and getting second of cost operating the absenteeism forces place with I into XX/X you the XX% they of is $XX half schedules.

take So, with of lot half the issue is very numbers the and make things strong. in the X will second your And year, the there's of I years. not great a the but that look of business comment

declining me And exactly little beautifully revenue to our day, growth we nothing company came a year is year. again, first into doing and the the grow we its It shake way, by have in we pretty think will to to said I evaporated. And do get I we growth would wasn't not COVID was grew had declining that significantly. going volume growing. are priority and this and with that. was do. what And from going We that. and almost last set of very the will end beautifully And

be and be our topline we've which of growth about years skeptical it. what -- identified we in one pipelines is our delivering we rate, year again. organic were very are opportunities half sure, believe that will ago the a people And delivering, and our love I bolt-ons have part and I this that will But For beautifully. of plate

that that we which The going and we algorithm. $XX business to nickel the forward building future, more declining and or up bottom-line would we can it thing operating years a to fantastic on four in setting or XXXX our we're right would they reactions now, deliver making are three because wanted doing million because that as still I income, changed. track. the income, killing for X/X/X of a after was than -- step, market strong growth, knee-jerks that -- help said do be. of is are It dime. were all us which focused repeatable, the Nothing's like can't with after were second if first go operating a is and I stabilized top that, for will be The ourselves that I company years, on is five deliver we the a great numbers as sustainable investments, up company to

Randall Stanicky

All Murray. right. Thanks

Operator

today Gilbert from Trust. question go ahead. Gregg next of Please will come Our

Gregg Gilbert

with in you? meaningful on announcement. Thanks. do product already Or when to does it the actually arrangement what for differentiate in Perrigo? And dispute and steps latest to CBD And on the other you. on based proven are know select purity them terms Thank And to proof probably rely rely Kazmira next second I Good patients helps does long-term Kazmira the you revenue? And then a this you certainly do way? when? morning. to But you play. your on my Irish the it ability CBD you line thoughts and we simply things that Murray, consistency? realize on what and the then your select led expect about that is think of could question is be a

Murray Kessler

on latter. is the it Well, Kazmira,

you've think that just got right. I So

to our to to that goal. certified, manufacturing metal your able a free, point, them part dollars that's the THC-free, meet scale to have be private et have practices. of relatively we And didn't -- of with all exclusive small, get cetera. be CBD that. rights good same first pride Kazmira, label they will and only, obviously and put on able But we And the As work starting practices. up they contaminant off, And homework. those to and they're FDA you've done being all themselves to to And are

would for we it, products. done And can to So it controls. don't say a will do. And able of noted way. are -- want be smaller they They're on it things all and Perrigo a we on you scale. do don't but been our much I they do be in we know, Once comfortable get to that, processes in now, for launching all mean to the the say, when they it's ask investments customers that, but equipment, I

next from to wouldn't surprised I of so, years, products couple see certainly, months XX next the within see to the not Perrigo. be And us of starting

it the own of And think some on XX% it before faster because go API, they see spectrum that. see, but that relied that, efficacy. it CBD this that's does. way, CBD -- that them stake. level But driving thought a And doesn't that isolate is that else in they CBD can dry it the to an isolate. for reliable. on, of ship -- primarily it branded for we'll through and Wild oil, clean it's say that it's You'll by them and full It opposed everything they're it -- as products, limits a and it's by on really we then when that when be that have the get CBD And through potential out And Wild, API, Kazmira, controlled takes THC-free. as and says West, us, that a the has THC-free, today for has the may the it, the a

So a a a we at longer-term -- I'm think excited but you're about it, of it's play. of first. right, way it bit But

done, Maybe scale First is branded, FDA does we'll getting that place. on we’ll Once not all Kazmira in the it. maybe certification is work something the with of see.

out, third near we're on label, preclude on then it. give would step probably some is think, movement internationally us, that take the -- But us things Next going be And and ingestibles in I a some clinical think private expecting like FDA more doesn't guidance which other that, traditional for future. doing There years to trials efficacy, from there's confidence. to things. that the and because I that's will on the few some be step especially

of through, if We'll get of done. reasonable it it or that we right it and the get either; we it judicial think that start we all process is to the hear else I to gain everything quarter, to probably judge, we believe judicial dramatically to answer Irish that review. putting job We're way, lot -- we did he team you there under the be legitimate legal the relates our case in and some legitimate dispute tax with I said to the first expectations Irish And win, view by upheld to a have -- buy where won when some don't flawed. think, review should to still it not. as back calculations go kind capital that our And now of was in as expectations, down. is normal an the appeals and to will tax will -- it ever months This a creates the revenue had off, that a we take we will versus stands kind If I or be now, a number right of why the law. But an We was appeals As excellent the going court you. time get when knock six see -- saw trade A, will we any that regard. willingness during within me are it's that one. if there, Irish be ultimately the in the think expectations out the were

So we're is significantly. a almost you improved that believe assuming do, if I upside has the in that our and Perrigo, see reflecting scenario sheet of stock, any lot for you which balance

scenario So there in to is. strong we're almost a handle any position

Gregg Gilbert

Thanks.

Operator

ahead. from go Elliot Our next question James. Please of Raymond Wilbur will come

Elliot Wilbur

Thank you. Good morning.

And segment in in and maybe segment. but number more bit the you there's on provide curious, that's could First competitor the pressure terms business? it's incremental question that SKUs, I'm little looked normal would specifically what product, the pricing if the dominant Generally, the think language what part in it's guess, obviously, CSCA of sense, a always across then versus release business, seems most CSCA the a on around and your pressure. understand not like the recent I given anomaly. of somewhat an probably CSCA language I just I Rx reserved share the trends? a that, segment but Makes for just of press magnitude, clarity like pricing specific this drives an quarter

of market? shelf-space in understand erosion a that competitor drive So, trying as a there is outside dynamic coming the more kind And or might just it quick pricing then pressure new to just just price follow-up. the or buying

any the saw that losses? include CSCI, you perhaps guys or product metrics relative you over-performance you. You CSCA didn't call individual for out or segments anything within of of underperformance could Thank where more terms in wind the

Murray Kessler

to I'm that. but Okay. revisit I'll trying do that,

and that's share most are -- are part, is Investor up high. question, I that aren't pricing On answer the get a X of The on our your how in And U.S. why is pressure presentation label your issue, the market first for if the and out showed Day pricing sometimes revenues has we -- I pressure. May the supplier we revenues Perrigo's that the as the private

increase shelf. or for the not. That's We to volume growing of is go our or price always price -- whether a dime target at just to been CTI remember, do bets. a than on a the with So, deciding it's the faster to raise and has They're take or right? me the normal would average, whatever. don't over CVS, get doing President the in we Walmart I it's the the of our -- business, And bid nothing don't tell forever, say, of revenues. couple But to over have it's past price old past revenues. percent It or part set not business. our

revenues, competitor. if having we try a and general, put for to new competitor new Our a we And They'll up bid. out end it's products not negotiate. in

was competitors omeprazole regulatory on private pricing for finally the the got the we out the of in example, pressure the a last with there end one it from that with the manufacturers more years ANDA, to for where year approval. year, approval only at would label regulatory we were So of couple carry

for them, able that to try cherry-pick in try and underprice now they're for So and us. us they'll come to compete and

say, wasn't we're yes, take but area, And or little or items to a and typical the distribution back new we on on got But that to add XXX bottom-line, you providing products, add bit as hand, other are new we alert. the red or give this you've negotiations. meant we On go you. XXX and if those products a

business of to early quarter in year second pricing business was have either part those CSCA, In bids was would which in is normal a next or on year. back COVID; quarter the the this because the good of later that fact, been pushed most of actually for normal a were level

So on really the of carried the in our say just have impact pricing, It plan an all it over through that and prior issue of under normal of that. second the Pain, of we’re of that multiples year. us. set half wasn't we ahead started the of I up. And estimates performed, We're U.S. quarter. Categories wasn't let was we're medicine much from on -- that's things year. normal, supply never for of at the I the go to would over in that still

products. area, profitable That to mix doing on the Fantech a at multiples. we're because Allergy -- because was bit gross margin fantastic a affects strong. component. the and likes that GI as little be it's banning So of not continues We're very in well the

in we went consumers areas the because but that have it category, of the hurts For us, us helps shares larger it sort to.

Cough here, So growth the business cold cough again. of our but way July. all started of strong, back half is coming to probably cold out And our of strong. recovered giveback, RGI as was but almost

buying business heads, has travel replacement a that's challenged, couple recovered weren't people beautifully. else off. strips -- et miss? that of it cetera, Nicotine what months like replacement But we its Again, wanted had -- toughed bit, It again, regimented it. was where back to So They again, when I did trajectory. stocked up. and that got a product to you've it's they a whitening Care, -- replacement, had nicotine things and but growth it's component was make consumers sure a very but Oral

system fantastic I've as formula, that's challenge been we with to. to talking U.S. Infant to where, want having feel be since we do got COVID. I here a us I plug the And And about, promote have business. aggressive. about got our can't they continue the can't issues. major We nothing So capacity tax. that, way we

gave they a got that we're the in talked we've capacity but take We And back. that time So of past open. about investments to good the then significant some -- making, we we surge. it get

question said So thing, our that people then what they just I you of business I we business a question ability would way can we get what be demand. Same international. the not a that heard, that think thought And them expect. growing would on it's I covered, like. It's of But you to all. about products And supply. the helpful, demand that

quarter got and hurt. treatments, I school. in like hurt Europe much I either But CSCI or as school lockdowns companies, the our branded maintained in major that was by gained was lights think aren't kids in outperformed we categories the all think share during market business the as closings, and if

-- businesses about do visits hurt. maintenance to products probably for get the and going into return. You're patients aren't to We script. Care, I were that dermatological to RX just is enough, I you? vacations, have of RX. one areas travelling they'll On doctor Sun go open versus the our people Did those than to get our not left more cover the But routine out others going buy scripts. need it. hurt

how So recovers. we'll that see fast

Elliot Wilbur

Thank you.

Operator

Please Stanley. next David of go question Our Risinger will ahead. today from Morgan come

Murray Kessler

Hey, David.

David Risinger

on the questions, I of Murray, I may. performance. if couple Hey strong congrats a have very so

enter claims? respect but efficacy responsible pharmaceutical Second, manufacturing how I CBD launches high-level so? a CBD ahead think the to the watch characterize conduct consumer that controls your market associated frame of cost try the sense Thank see the that a it, interested points of we with to surge as new year then demand you to does may next given part makes there's three clinical an you. to for third, to in regarding Perrigo I'm to comps? studies model important to or over plan those to Perrigo with in surge most first, obviously, lot opportunity start expertise, any launches of this and and the about way for good top the we company's So you'd consumer support in as And this, product relative any but missed missed I call, have with would the XXXX, us, sort XXXX

Murray Kessler

we'll looking or wait go on for to pathway we aggressive mouthful, is, Well, its full think longer-term there. play, I in that on And ingested But as to get out critical. the for your there view trials first products studies, get as yes, a comes clinical way, answer yes. what claims, the to all for. anxious efficacy one see lot last I on a see they'll that's the the CBD would those. but on I'm are well by to the at of for but question be was potential, the not probably efficacy guidance efficacy more a the category it the

I'm invest way, the we'll the other branded So on budget than more our be. to consumer successful in a start our levels. Voltaren, they about opinion, too, that equivalent side, in yes, normal super within and the my know On by are, which say, hesitant you more launches, we'll the Voltaren successful

track third on And quarter. still good. that's So that's for

And so be will that here soon.

R&D. in we've that, investing been Beyond

make a one we I'm to -- nicotine here of five couple We have areas the is -- pipeline. we're looking gave on products. that of on that infant what willing formula, strategic a of I growth we million you core pushed a -- The my our still only not on on, train back one in for sure, say $XXX in thought well, not the our new new and is one as product the preview got of it is,

So the you're some have year products going to first. in half being new of effective the scheduled second

worth natural about that here. line So million one. that expertise I which we and have leverage was And Europe, natural in a talked products May the of science-based in then $XXX sales about a business based had that of we Xth, naturals our And one would on nothing second products. basically based you told become natural science-based

surge it launch have bunch if Prevacid, remains So line would on a to but I track. dozens the putting levels spoken don't because and get them, like disadvantage. well. of are want would that be that is Product out, -- launching And doing year it's but products I a on to questions? Did I a think and the demand of of as right share expect year, it that them, be next haven't second test question? a level be we've there that, company Or into of too, different pushes and but and what's investment, could fully the we're years your about this at spending we does fit others, all CBD it the track. bought pulls? half, what bigger I on and few we but surgery basically, and a consumer markets translate that cost, was how into

what I about. think Here's

a and coming lopsided. fair of basic you made think year out amount the has surge that the I got

what year, giveback we're and it this about cold the retaining remaining of cough ongoing Ranir year. XX% does the on our affecting measuring that I us other we've season that products I'll put guidance this be an along, are much said the number, but lapping gearing that so But it on for We'll believe July, with all is ultimately so forecasted I small. X% organic believing So we're need that don't goal haven't basis depending that's how consumers the the half probably had positive bolt-ons into really in half. and or first We've impact what beat far is. and because

airfreighting you have they coming XXX% right sheltering API. paying got is everybody them the incremental plants you you fire home. or some are. else's overhead. cost, you more don't that when demand way treat them, them bonuses have are the being for we them, givebacks, your products, When absenteeism, off of you XX% give treat way lay on you're into the certain the So, they people to and at a believe what lot you're brave kind When them you When reward and

day, we where were were were And hours and a employee provided we were being rewarded the gave to them. high the XX%, for meals other incremental that was were coming a we overtime we people we and those week. who XX% what -- available, the we we those paying unemployment were in supplemented days seven So, running in believed them those were they bonuses, plants XX paid that of costs keep because for also of risk, at

but about it? the early a it, I bit how to expect think do I'd So, reverse. I'd expect normalize. it about It's to be talking

bump potential next strength we're in I and will one-time on to year. near But of that you think I come based these a up rather at good than COVID and be growth to out lots the a with on targets think thing has having our explain Perrigo that it's staying growth, it costs back declines original getting project should on us ramping of momentum the get fundamentals costs and looking track.

my X/X/X. two thing these haven't difference inch be little lumpier. it will an would years, from is bit swayed a So, only I for The be

first office reverses the some at the impact way recovers fully negative year. up of in -- costs That half year, a half some impact down second open the and -- of this year. negative Rx until in next negative the So itself impact continuing doctor's up of and the up fully and has Scripps

you you but that on initial these don't full cost, some hopefully, brands the You'll but on are recovered that have probably then products of year, down. do have better of surge,

And got it's think now. seeing that So, much months we're around our lumpy. I I arms than We've out it. track. worried right three shake more But about general, think in I'm question was last on I ago how it

David Risinger

Thank you.

Operator

Fargo. from will Hughes go David today ahead. come Please question Wells last our And of

David Hughes

so much. Hey, thanks

in expand on it you was gross the Murray, Just margin think performance could consumer? down points. XXX I basis

the Secondly, So a year? margins should about clearly and the gross the spin XXXX? said think there's Rx? for or consensus quantify then sales the than in you second year for but press And think think what how timing about you're I doubled? just we they has -- improving next thinking of mix there, how quarter? the a could a the sale Thanks. release I e-commerce that impact finally, half were of bolt-ons

Murray Kessler

I'll can bolt-ons, and you add why bit and want, if of those, the a first little talk that. two you Ray, don't about you to do

Ray Silcock

Okay.

that decline addition is were half had the factors pointed Oral-Care as that basis business, the of on lower So, you quarter, gross on line. margin, we've XXX first, occasions, Oral-Care the margin average impacted a XXX about out, the points because basis in point the has the two major the we the on said business which second a of as several

had, the specifically nonessential was significant saw other high this high-margin basically quarter already The the we points CSCI sort came of parasite and half products during has second referred a in second products, if products, the we about you loss of the year but some both our Murray of products weight sales. that loss of which were the of of mix as to, and XXX in in drop products, These quarter. margin, like, basis

of July. acquisition in balance the I respect the of anniversary terms in this In should anniversary year, say, think -- with the Oral-Care, to so we July, we it

respect balance uncertainty to the any questions in respect approach think on the year, we into uncertainty. forward -- that the there's have going the tried to guidance that conservative margin? So balance think, still of of With still further have tailwind. reflect we In the you the And our CSCI in so did don't to there's I year. I to that business,

David Hughes

increase in about No, XXXX consensus I'm modeling an wondering has that year-over-year? just

Ray Silcock

be some think -- difficult would make at that to in in start early at talked this about QX in think I to it's we our about point but XXXX, think really of not there to far I those -- XXXX time. headwinds that prognostication Yes, I very the our that the the But again, think moment. we be into I would there expectation -- future would mean, given it's see I

Murray Kessler

is that Yes, on it margin not Ranir CSCA, of incremental. I to But in that in XXX% the no a mean, things but saying. the a it a like is big just or consumer issue, fundamental bought you lower to was -- was margin. to that item gross add change was look Ray a company. It's had which had became lower company down made trading further down which And so it mix margin and just weakness especially gross the -- the it a what one items,

So -- going forward. that's gone but

which of the the get year. will other But then I'm of a like the COVID of into world we get out a there the a spending. sure and should back have margin making So this -- again, we comparison we thing gets good go of making phentermine some if call, the we're needed that did of year, the you from stopped again like reverse which negative things to vaccines as you of and were and in in and half opposed on remember And last that, won't the we making the things world that you COVID which costs world is, it were handle year-over-year hopefully, higher beginning and lot the and first probably a what products, and that. -- portion products back itself now. items needed, portfolio bunch favor is, of famotidine stopped --

comparisons the ought on those And so to pretty be good.

there So, improvement number positive gross a and are I margin on factors, a that but in CSCA, improve. of you should saw think sequential

the have you costs, and cetera. -- hopefully So, overtime et won't

some we're So, the are point. not an at drivers that of clear, it. hear and We it's going the -- and But focused area on. focused we're this loud -- were I it's on headwinds think we big everybody not

business. the help like those As say off around at But e-commerce give -- of top numbers. it can want them -- was because don't have I head to look you my we by I X%… me Brad Brad something them

Brad Joseph

call it, around Perrigo. total across or Up $XX million, XXX% to X%

Murray Kessler

bigger percentage customers certain it's But certain businesses. and of right. All actually much a

customers, a that our business. outside five -- of customers. are X% top five have of We in really retailers by the top couple but Amazon we other our say it, to of I'm of to customers who business name, not invested it's it's our -- at have going in have where them XX%

probably a And number. of we're percentage us it big e-commerce in adding country expansion it's lots entire so in percentage, more offset, for around varies. in How of the every just height pain literally in segment on the probably traditional in-store obviously, category, it but enough e-commerce. The what is big tracking and you're very And grocery, probably still running OTC. item. this What if it's It's was -- regimented about it have and yet, from the on the top by within to came and the the a it's thing It's growth with to the would to frankly, offset difficult And during the it was products So the And a RX? of, that higher see decline. In takeaway to stores. IRI, important lot to MULO, of Perrigo diligence. is us, third? much phases, because big within cash. we're better adding also from same tend total not crisis. XXX additional bolt-ons Bolt-ons, due to brick-and-mortar quarter Europe, room points that you're drug, e-commerce. a you do total kind basis business, consumer bit thinking We, of in of built a still halt it's a of

So we pipeline process. some are in our had beforehand. the restarting We

a in holding Right full But it's running see may crisis. up and pretty now, old position. through something you well we're process again. isn't multiples this not in up but later, consumer than fully the -- are good So sooner

I believe, and there went in that no it manage invest this we'll mix the of side. buys is on pipeline has which show until strategy. will bottom-line. out So, multiples We'll I resolves in their until a organic Rx value that Business come thing low, year the it last consumer -- priority hoping that's We're row later Rx was that an invest changed in Rx a separation, it's it's me see. the so and volatility time Yet, grows we we'll but And of and growth. opportunistic that buyers our giving take itself, early here, reliably be some boatload our may is X% in no performance that industry and the will that off change. the would second there's innovation only Yes, the from especially say themselves here. are strategic of still cash And thrown and part out were that it. be, for when our -- cash I in important top strategy,

the looking the on I the did. the that proved when refine kind get about were and Rx multiple we think of kind sold times, we sale were selling talking at when XX numbers a can I we around we we would business, double but at with -- portfolio, which So U.S. of Rx of

we but will management not. part time. it important make So, great sure it it's that going no they're time. slower of right collected It's some than and would leadership. and will they're family isn't takes until take we business now like an under the and And Perrigo And --

David Hughes

Thanks very much.

Operator

time, Ladies Kessler I'd will And turn to this session. and conclude at for any the like back Murray our conference closing gentlemen, question-and-answer to over this remarks.

Murray Kessler

I questions that into and again. something the was and and years. it proud that would back Perrigo make pattern look now then just the in than to of an happens company over today, that team a was be done was when a And are couple time. to the we've of delivers gets that I several different sure work comments under here Yes, folks ago But accomplished there's is years management winning. over we like I lot not that the and a I'm mean, promoted reflection of changing This six-month a and bought beginning of Ray reiterate, on to of couple other and dramatically what joined, past Perrigo. that's I that entirely I got it that success is period we've in the

on focused a are building company. great We

We have growth. returned the to company

have talent the We management the this built organization. in and

building and organization. winning this culture have We are to restored a

coming whether through probably in, We e-commerce and or product the our new forward. it have going anticipated and bolt-off innovation opportunities pipeline, or of new filled there's what growth triple be adjacencies I

a be we kind deliver to which and business is company we delivers be its able over part of want company getting to and of We infrastructure be have the the same for growth finishing and the sustainable long-term, to that business, and income years are continuous, to to a rapidly off in us position time, consistently while the the first that want new work investors on with capital our the stabilizing time do at hope to operating pipeline. investments the on And business product objectives, kind that of. we doing accelerating of

year. everything the So, up on society, right hasn't of proud makes the the the in basically, that track exceeding I'm and to I uneven meeting It this lumpy. right believe, of half we're this get it despite on crisis or through to expectations. were people went first through to bit a its But this year set for world company crisis, I quarter-after-quarter-after-quarter and we on changed company are shocked it. be track. the And anything. a us leading continue through rise I'm and keep able after-quarter, occasion track, deliver long-term that helps the

you thank your Perrigo. interest for in So,

Operator

and the thank we has concluded gentlemen, today's for and Ladies now conference presentation. you attending

may now You lines. disconnect your

Perrigo (PRGO) 5 Aug 202020 Q2 Earnings call transcript